{"id":32632,"date":"2018-01-30T16:58:24","date_gmt":"2018-01-30T15:58:24","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=32632"},"modified":"2018-01-29T15:35:34","modified_gmt":"2018-01-29T14:35:34","slug":"eximmium-helmholtz","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/32632\/eximmium-helmholtz\/","title":{"rendered":"Eximmium: Helmholtz spin-off secures start-up funding"},"content":{"rendered":"

The Helmholtz Association is funding a new spin-off from the Helmholtz Zentrum M\u00fcnchen. The company Eximmium aims to use a new process to produce antibodies for diagnostics and therapy.<\/strong><\/p>\n

The medtech company Eximmium is receiving \u20ac115,000 each from the Helmholtz Association and the Helmholtz Zentrum M\u00fcnchen, a total of nearly a quarter of a million euros. The team led by Prof. Dr. Reinhard Zeidler and Dr. Kathrin G\u00e4rtner works with small bubbles called extracellular vesicles. The company uses these bubbles to produce new antibodies for cancer treatment and diagnostics. These antibodies are designed to be particularly powerful.<\/p>\n

Eximmium can become an \u201cattractive partner for pharmaceutical companies\u201d<\/h3>\n

The team also aims to demonstrate the potential of their method clinically: A first antibody targeting malignant brain tumors will soon be tested in patients in a phase 1 trial. Further antibodies with diagnostic or therapeutic potential are in the pipeline. Prof. Dr. Reinhard Zeidler<\/strong>, head of the \u201cPrevention and Immunomodulation\u201d working group in the Gene Vectors Department at the Helmholtz Zentrum M\u00fcnchen, says:<\/p>\n

\u201cOur portfolio forms a solid basis for a spin-off.\u201d<\/p><\/blockquote>\n

The goal, according to Zeidler, is to validate the antibodies preclinically and, ideally, license them to an industrial partner. Already approved therapeutic antibodies are among the most commercially successful drugs. The scientist says:<\/p>\n

\u201cWe therefore believe that a spin-off can become an attractive partner for pharmaceutical companies.\u201d<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"

The Helmholtz Association is funding a new spin-off from the Helmholtz Zentrum M\u00fcnchen. The company Eximmium aims to produce antibodies for diagnostics and therapy using a new process. The medtech company Eximmium will receive \u20ac115,000 each from the Helmholtz Association and the Helmholtz Zentrum M\u00fcnchen, for a total of nearly a quarter of a million euros. The team led by Prof. Dr. \u2026<\/p>","protected":false},"author":26,"featured_media":32633,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5638,1],"tags":[371,3001,3002,243],"acf":[],"yoast_head":"\nEximmium: Helmholtz-Ausgr\u00fcndung sichert sich Starthilfe - Munich Startup<\/title>\n<meta name=\"description\" content=\"Die Helmholtz-Gemeinschaft f\u00f6rdert eine neue Ausgr\u00fcndung des Helmholtz Zentrums M\u00fcnchen. Eximmium will Antik\u00f6rper zur Diagnostik und Therapie herstellen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/32632\/eximmium-helmholtz\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eximmium: Helmholtz-Ausgr\u00fcndung sichert sich Starthilfe - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Die Helmholtz-Gemeinschaft f\u00f6rdert eine neue Ausgr\u00fcndung des Helmholtz Zentrums M\u00fcnchen. Eximmium will Antik\u00f6rper zur Diagnostik und Therapie herstellen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/32632\/eximmium-helmholtz\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-01-30T15:58:24+00:00\" \/>\n<meta name=\"author\" content=\"Simon Tischer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon Tischer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/\",\"url\":\"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/\",\"name\":\"Eximmium: Helmholtz-Ausgr\u00fcndung sichert sich Starthilfe - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/01\/drew-hays-206414.jpg\",\"datePublished\":\"2018-01-30T15:58:24+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\"},\"description\":\"Die Helmholtz-Gemeinschaft f\u00f6rdert eine neue Ausgr\u00fcndung des Helmholtz Zentrums M\u00fcnchen. Eximmium will Antik\u00f6rper zur Diagnostik und Therapie herstellen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/01\/drew-hays-206414.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/01\/drew-hays-206414.jpg\",\"width\":2500,\"height\":1065,\"caption\":\"BioVaria\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eximmium: Helmholtz-Ausgr\u00fcndung sichert sich Starthilfe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\",\"name\":\"Simon Tischer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"caption\":\"Simon Tischer\"},\"description\":\"Von Dezember 2015 bis Juni 2023 war Simon Tischer als Redakteur f\u00fcr Munich Startup t\u00e4tig.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2018\/01\/drew-hays-206414.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2500\" \/>\n\t<meta property=\"og:image:height\" content=\"1065\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eximmium: Helmholtz spin-off secures start-up funding - Munich Startup","description":"The Helmholtz Association is funding a new spin-off from the Helmholtz Zentrum M\u00fcnchen. Eximmium aims to produce antibodies for diagnostics and therapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/32632\/eximmium-helmholtz\/","og_locale":"en_US","og_type":"article","og_title":"Eximmium: Helmholtz-Ausgr\u00fcndung sichert sich Starthilfe - Munich Startup","og_description":"Die Helmholtz-Gemeinschaft f\u00f6rdert eine neue Ausgr\u00fcndung des Helmholtz Zentrums M\u00fcnchen. Eximmium will Antik\u00f6rper zur Diagnostik und Therapie herstellen.","og_url":"https:\/\/cms.munich-startup.net\/en\/32632\/eximmium-helmholtz\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2018-01-30T15:58:24+00:00","author":"Simon Tischer","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Simon Tischer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/","url":"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/","name":"Eximmium: Helmholtz spin-off secures start-up funding - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/01\/drew-hays-206414.jpg","datePublished":"2018-01-30T15:58:24+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d"},"description":"The Helmholtz Association is funding a new spin-off from the Helmholtz Zentrum M\u00fcnchen. Eximmium aims to produce antibodies for diagnostics and therapy.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/01\/drew-hays-206414.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/01\/drew-hays-206414.jpg","width":2500,"height":1065,"caption":"BioVaria"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/32632\/eximmium-helmholtz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Eximmium: Helmholtz-Ausgr\u00fcndung sichert sich Starthilfe"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d","name":"Simon Tischer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","caption":"Simon Tischer"},"description":"From December 2015 to June 2023, Simon Tischer worked as an editor for Munich Startup.","url":"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/"}]},"og_image":[{"width":2500,"height":1065,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/01\/drew-hays-206414.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1559736769:24","_edit_last":"22","_yoast_wpseo_focuskw":"Eximmium","_yoast_wpseo_metadesc":"Die Helmholtz-Gemeinschaft f\u00f6rdert eine neue Ausgr\u00fcndung des Helmholtz Zentrums M\u00fcnchen. Eximmium will Antik\u00f6rper zur Diagnostik und Therapie herstellen.","_yoast_wpseo_linkdex":"86","_thumbnail_id":"32633","wbounce_status":"default","_yoast_wpseo_primary_category":"5638","_yoast_wpseo_focuskw_text_input":"Eximmium","_yoast_wpseo_content_score":"60","ms_image_format":"","_ms_image_format":"","ms_dachzeile":"","_ms_dachzeile":"","ms_bump_post_date":"","_ms_bump_post_date":"","guest_author_name":"","_guest_author_name":"","guest_author_image":"","_guest_author_image":"","guest_author_description":"","_guest_author_description":"","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/32632"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=32632"}],"version-history":[{"count":0,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/32632\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/32633"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=32632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=32632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=32632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}